Overview

Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

Status:
Completed
Trial end date:
2013-01-04
Target enrollment:
Participant gender:
Summary
Comparison of 3 dosing regimens of Advagraf to determine if there is a dosing regimen which may have the potential to cause fewer kidney problems.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Antibodies, Monoclonal
Basiliximab
Methylprednisolone
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus